No abstract

No abstract

No abstract

Dear Editor, We read with great interest Deana C's critical overview of emerging data amidst the novel coronavirus disease 2019 (COVID-19) pandemics about its treatment approach [1]. This is an increasingly relevant topic of discussion in all medical specialties including neurology and psychiatry. We expand the discussion here. COVID-19 greatly impacts healthcare systems on a global scale. The widespread societal consequences understandably urge researchers to share information that may contribute to our understanding of this disorder. The plethora of publications regarding SARS-CoV-2 infection initially focused on general clinical presentation but the focus widened to include specific organ involvement as well as negative mental health outcomes. Ling Mao and colleagues' highly cited case series of hospitalized patients is an example of such efforts [2]. Recent reviews of the neurological symptoms of COVID-19 raise relevant questions regarding the quality of the scarce data emerging about neurological involvement [3]. Evidence of neurological disease associated with SARS/MERS-CoV favors the neuroinvasive potential of SARS-CoV-2 [4]. Most

No abstract